420 with CNW – The White House is Reviewing FDA Research Guidelines on Marijuana and CBD
For the past year or so, the U.S. Food and Drug Administration (“FDA”) has been under mounting pressure from advocates and stakeholders to create a comprehensive regulatory plan for the growing CBD industry. Although the nascent industry is already worth millions in sales and filled with tons of sellers, it is barely regulated. Not only has this made it difficult for businesses to operate, but it has called into question the efficacy and safety of the products being sold. Last week, the agency submitted a draft of a federal plan for marijuana and CBD research titled 'Cannabis and Cannabis-Derived Compounds:…

















